Total Payments
$2,272
2024 Payments
$155.60
Companies
12
Transactions
50
Medicare Patients
8,827
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$2,237 (98.4%)
Gifts$19.40 (0.9%)
Other$15.99 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,237 | 48 | 98.4% |
| Gift | $19.40 | 1 | 0.9% |
| Entertainment | $15.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $551.08 | 12 | $0 (2024) |
| Alcon Vision LLC | $471.58 | 7 | $0 (2023) |
| Genentech, Inc. | $315.54 | 4 | $0 (2023) |
| Alcon Laboratories Inc | $306.11 | 3 | $0 (2018) |
| Alimera Sciences, Inc. | $248.18 | 13 | $0 (2024) |
| Mallinckrodt LLC | $123.53 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $99.79 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $88.58 | 1 | $0 (2019) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Kala Pharmaceuticals, Inc. | $17.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155.60 | 7 | Alimera Sciences, Inc. ($86.85) |
| 2023 | $696.96 | 15 | Alcon Vision LLC ($224.43) |
| 2022 | $534.42 | 10 | Genentech USA, Inc. ($298.16) |
| 2021 | $246.16 | 7 | Alcon Vision LLC ($194.62) |
| 2020 | $38.05 | 2 | Carl Zeiss Meditec AG ($19.40) |
| 2019 | $141.11 | 2 | Novartis Pharmaceuticals Corporation ($88.58) |
| 2018 | $326.81 | 5 | Alcon Laboratories Inc ($189.17) |
| 2017 | $132.93 | 2 | Alcon Laboratories Inc ($116.94) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/21/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/05/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/01/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2023 | Alimera Sciences, Inc. | YUTIQ (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/23/2023 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $121.01 | General |
| Category: Ophthalmology | ||||||
| 10/16/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/27/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/15/2023 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $127.41 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/28/2023 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/17/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/15/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/24/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $120.74 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/05/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2023 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $103.42 | General |
| Category: Ophthalmology | ||||||
| 03/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/20/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/10/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/12/2022 | Genentech, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $106.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/17/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,070 | 27,319 | $2.9M | $1.0M |
| 2022 | 12 | 2,190 | 9,162 | $2.1M | $681,229 |
| 2021 | 12 | 2,283 | 6,863 | $1.7M | $563,340 |
| 2020 | 13 | 2,284 | 7,392 | $1.6M | $482,458 |
Total Patients
8,827
Total Services
50,736
Medicare Billing
$2.8M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 77 | 22,621 | $1.4M | $640,189 | 45.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 28 | 241 | $360,750 | $164,577 | 45.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 256 | 840 | $609,185 | $72,768 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 603 | 1,174 | $167,043 | $70,959 | 42.5% |
| 92134 | Imaging of retina | Office | 2023 | 710 | 1,710 | $247,679 | $46,300 | 18.7% |
| J3590 | Unclassified biologics | Office | 2023 | 173 | 497 | $56,431 | $22,320 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 102 | $21,193 | $9,210 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $17,415 | $6,295 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $16,198 | $4,581 | 28.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 14 | 14 | $4,854 | $413.15 | 8.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 39 | 366 | $515,067 | $260,235 | 50.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 32 | 3,840 | $232,958 | $112,800 | 48.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 259 | 858 | $631,302 | $77,327 | 12.2% |
| J3590 | Unclassified biologics | Office | 2022 | 228 | 775 | $150,411 | $74,794 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 606 | 1,147 | $161,474 | $69,324 | 42.9% |
| 92134 | Imaging of retina | Office | 2022 | 712 | 1,802 | $251,616 | $49,357 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 210 | $46,516 | $16,948 | 36.4% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 12 | 13 | $43,875 | $10,614 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 60 | 60 | $13,442 | $4,266 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $16,660 | $4,264 | 25.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 43 | $2,703 | $832.96 | 30.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 11 | 13 | $4,168 | $466.14 | 11.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 37 | 362 | $412,906 | $259,650 | 62.9% |
| 67028 | Injection of drug into eye | Office | 2021 | 271 | 871 | $581,701 | $81,421 | 14.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 614 | 1,307 | $171,683 | $79,575 | 46.4% |
About Dr. Peter Blackburn, MD
Dr. Peter Blackburn, MD is a Ophthalmology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336196815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Blackburn, MD has received a total of $2,272 in payments from pharmaceutical and medical device companies, with $155.60 received in 2024. These payments were reported across 50 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,237).
As a Medicare-enrolled provider, Blackburn has provided services to 8,827 Medicare beneficiaries, totaling 50,736 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Retina Specialist
- Location Lexington, KY
- Active Since 05/28/2006
- Last Updated 03/07/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1336196815
Products in Payments
- Constellation (Device) $553.26
- Vabysmo (Drug) $397.00
- VABYSMO (Drug) $298.16
- NGENUITY (Device) $224.43
- ACTHAR (Biological) $123.53
- YUTIQ (Drug) $110.63
- SUSVIMO (Drug) $106.66
- ILUVIEN (Drug) $104.79
- EYLEA (Biological) $67.70
- Lucentis (Biological) $64.80
- EYLEA HD (Biological) $32.09
- None Specified (Medical Supply) $19.40
- Iluvien (Drug) $18.65
- INVELTYS (Drug) $17.82
- California (Device) $15.99
- Cequa (Drug) $14.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Ophthalmology $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Ophthalmology $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Ophthalmology $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Ophthalmology $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249
Ophthalmology $75,249